We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+11.43%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$43.4B
AUM Growth
+$3.14B
(+7.8%)
Cap. Flow
-$115M
Cap. Flow
% of AUM
-0.27%
Top 10 Holdings %
Top 10 Hldgs %
13.22%
Holding
2,192
New
164
Increased
795
Reduced
936
Closed
172
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$193M |
| 2 |
Gilead Sciences
GILD
|
+$115M |
| 3 |
Tencent Music
TME
|
+$83.5M |
| 4 |
Kanzhun
BZ
|
+$76.7M |
| 5 |
Wheaton Precious Metals
WPM
|
+$68.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$189M |
| 2 |
Williams Companies
WMB
|
+$155M |
| 3 |
AYX
Alteryx Inc
AYX
|
+$94.1M |
| 4 |
AbbVie
ABBV
|
+$87M |
| 5 |
Amgen
AMGN
|
+$78.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.44% |
| 2 | Healthcare | 17.1% |
| 3 | Financials | 12.78% |
| 4 | Industrials | 10.38% |
| 5 | Consumer Discretionary | 10.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Organogenesis Holdings
ORGO
$179M
| $30.4K | ﹤0.01% |
10,690
-975
| -8% | -$3.31K |
|
1677
Unitil
UTL
$955M
| $30.3K | ﹤0.01% |
579
-234
| -29% | -$11.8K |
|
1678
Banner Corp
BANR
$2.6B
| $29.9K | ﹤0.01% |
623
-292
| -32% | -$13.7K |
|
1679
Deluxe
DLX
$1.08B
| $29.9K | ﹤0.01% |
1,451
-771
| -35% | -$15.3K |
|
1680
Insight Enterprises
NSIT
$4.85B
| $29.1K | ﹤0.01% |
+157
| New | +$29K |
|
1681
Herc Holdings
HRI
$4.77B
| $28.9K | ﹤0.01% |
+172
| New | +$26.2K |
|
|
CTLT
1682
DELISTED
CATALENT, INC.
CTLT
| $28.7K | ﹤0.01% |
509
-521
| -51% | -$28.2K |
|
|
HLVX
1683
DELISTED
HilleVax
HLVX
| $28.6K | ﹤0.01% |
1,718
-3
| -0.2% | -$48 |
|
1684
Arbutus Biopharma
ABUS
$1B
| $28.5K | ﹤0.01% |
+11,033
| New | +$28.6K |
|
|
UMH
1685
UMH Properties
UMH
$1.33B
| $28.4K | ﹤0.01% |
1,750
+10
| +0.6% | +$153 |
|
1686
MaxCyte
MXCT
$122M
| $28.2K | ﹤0.01% |
+6,740
| New | +$31.6K |
|
|
PRMW
1687
DELISTED
Primo Water Corporation
PRMW
| $28.2K | ﹤0.01% |
+1,548
| New | +$24.4K |
|
1688
Cytek Biosciences
CTKB
$641M
| $28.1K | ﹤0.01% |
4,187
+191
| +5% | +$1.51K |
|
1689
Sterling Infrastructure
STRL
$14.8B
| $28K | ﹤0.01% |
254
+2
| +0.8% | +$182 |
|
1690
B&G Foods
BGS
$255M
| $27.7K | ﹤0.01% |
2,421
-118,863
| -98% | -$1.24M |
|
|
HTBK
1691
DELISTED
Heritage Commerce
HTBK
| $27.6K | ﹤0.01% |
3,215
-1,641
| -34% | -$14.3K |
|
|
ZEUS
1692
DELISTED
Olympic Steel
ZEUS
| $27.2K | ﹤0.01% |
384
-94
| -20% | -$6.28K |
|
1693
Regency Centers
REG
$13.4B
| $26.9K | ﹤0.01% |
445
-210
| -32% | -$13K |
|
|
AHRT
1694
AH Realty Trust
AHRT
$467M
| $26.9K | ﹤0.01% |
2,583
-204,915
| -99% | -$2.32M |
|
1695
Hasbro
HAS
$12.6B
| $26.8K | ﹤0.01% |
475
-564
| -54% | -$28.7K |
|
1696
OmniAb
OABI
$632M
| $26.5K | ﹤0.01% |
4,883
-1,209
| -20% | -$6.96K |
|
1697
AlTi Global
ALTI
$364M
| $26.3K | ﹤0.01% |
4,640
+3,159
| +213% | +$19.5K |
|
1698
Global Net Lease
GNL
$2.05B
| $26K | ﹤0.01% |
3,344
-1,511
| -31% | -$12.4K |
|
1699
Nordic American Tanker
NAT
$1.69B
| $25.9K | ﹤0.01% |
6,615
+5,802
| +714% | +$24.4K |
|
1700
Prime Medicine
PRME
$544M
| $25K | ﹤0.01% |
+3,576
| New | +$27.1K |
|
Similar funds
Federated Hermes's Q1 2024 Portfolio in Review
As of Q1 2024, Federated Hermes held 2,192 positions worth $43.4B, up 7.8% from $40.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Federated Hermes's Q1 2024 filing shows 164 new, 795 increased, 936 reduced and 172 closed positions. Its largest new stake was Kanzhun: 4,861,533 shares worth $85.2M. The largest sale was Medtronic, an estimated $189M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
- Federated Hermes's largest Q1 2024 buy was Kanzhun: 4,861,533 shares worth $85.2M.
- Federated Hermes added most to Bristol-Myers Squibb in Q1 2024, an estimated $193M increase.
- Federated Hermes's biggest Q1 2024 reduction was Medtronic, cutting an estimated $189M.
- Federated Hermes fully exited Alteryx Inc in Q1 2024, selling an estimated $94.1M.
- Federated Hermes's ten largest holdings make up 13% of its $43.4B portfolio in Q1 2024.
- Federated Hermes opened 164 new positions and closed 172 in Q1 2024.
- Federated Hermes's portfolio value rose 7.8% quarter-over-quarter to $43.4B.
Based on Federated Hermes's 13F filing for Q1 2024, filed 14 May 2024.